Page last updated: 2024-11-08

ammodendrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ammodendrine: structure given in first source; RN given refers to (R)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ammodendrine : A piperidine alkaloid that is piperidine substituted by a 1-acetyl-1,4,5,6-tetrahydropyridin-3-yl group at position 2 (the 2R-stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID442625
CHEMBL ID464777
CHEBI ID2670
MeSH IDM0187497

Synonyms (24)

Synonym
pyridine, 1-acetyl-1,2,3,4-tetrahydro-5-(2-piperidinyl)-, (r)-
pyridine, 1-acetyl-1,2,3,4-tetrahydro-5-(2r)-2-piperidinyl-
isoammodendrin
isoammodendrine
CHEBI:2670 ,
1-acetyl-5-[(2r)-piperidin-2-yl]-1,2,3,4-tetrahydropyridine
1-{1,2,3,4-tetrahydro-5-[(2r)-piperidin-2-yl]pyridin-1-yl}ethanone
ammodendrine
494-15-5
spherocarpine
1-[5-[(2r)-piperidin-2-yl]-3,4-dihydro-2h-pyridin-1-yl]ethanone
CHEMBL464777
d-ammodendrine
unii-u0x8i482c7
u0x8i482c7 ,
ethanone, 1-(3,4-dihydro-5-(2r)-2-piperidinyl-1(2h)-pyridinyl)-
(+)-ammodendrine
AKOS030229934
Q27105761
DTXSID70964226
1-[5-(piperidin-2-yl)-3,4-dihydropyridin-1(2h)-yl]ethan-1-one
AT20210
(r)-1-(5-(piperidin-2-yl)-3,4-dihydropyridin-1(2h)-yl)ethan-1-one
1-{5-[(2r)-piperidin-2-yl]-1,2,3,4-tetrahydropyridin-1-yl}ethan-1-one

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The LD50 of (+)-D-ammodendrine in mice was determined to be 94."( Ammodendrine and N-methylammodendrine enantiomers: isolation, optical rotation, and toxicity.
Chang, CW; Gardner, DR; Garrossian, M; Lee, ST; Molyneux, RJ; Panter, KE; Pfister, JA, 2005
)
2.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
teratogenic agentA role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
piperidine alkaloid
N-acylpiperidine
acetamidesCompounds with the general formula RNHC(=O)CH3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID401649Cytotoxicity against iv dosed Swiss-Webster mouse2005Journal of natural products, May, Volume: 68, Issue:5
Ammodendrine and N-methylammodendrine enantiomers: isolation, optical rotation, and toxicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.88 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]